2Arnett FC, Edworthy Sm, Block DA, et al . American Rheumatism Assotiation 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthritis Rheum, 1988,31:315 - 314.
3American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis ( 2002 update ) [J]. Arthritis Rheum,2002,46 ( 2 ) :328 - 346.
4Immunex Corporation. Enbrel ( etanercept ) for subcutaneous injection: US prescribing information. Thousand Oaks ( CA ) : Immunex Corporation,2006 Jun 6.
5Weinblatt ME, Keystone EC, Fnrst DE,et al. Adalimumab,a fully human anti-tumor necrosis factor ~monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant meth- otrexate : the ARMADA trial [ J ]. Arthritis Rheum, 2003,48 : 35 -45.
6Breedveld FC, Weisman MH, Kavanaugh AF, et al. A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adali- mumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment [ J ]. Arthritis Rheum,2006,54(1 ) :26-37.
7Jones G,Sebba A,Gu J,et al. Comparison of tocilizumab monoth~ra- py versus methotrexate monotherapy in patients with moderate to se- vere rheumatoid arthritis : The AMBITION study [ J ]. Ann Rheum Dis,2010,69( 1 ) :88-96.
8Nishimoto N,Miyasaka N, Yamamoto K, et al. Study of active con- trolled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI) :sigrtifcant reduc- tion in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy [ J ]. Mod Rheumatol, 2009,19 (1) :12-19.
9Schiff M, Pritchard C, Huffstutter JE, et al. The 6-month safety arid efficacy of abatacept in patients with rheumatoid arthritis who under- went a washout after anti-tumour necrosis factor therapy or were di- rectly switched to abatacept: the ARRIVE trial [ J ]. Ann Rheum Dis,2009,68 : 1708-1714.
10Boyesen P, Haavardsholm EA, Ostergaard M, et al. MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are inde- pendent predictors of subsequent radiographic progression [ J ]. Ann Rheum Dis, 2011,70( 1) :176-179.
7Prevoo ML,Kuper HH,Hofma V,et al.Modified disease activity scores that include twenty-eight-joint counts.Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis[J].Arthritis Rheum,1995,38 (1):315-324.
9Tsuchiya Y,Takayanagi N,Sugiura H,et al.Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome[J].Eur.Respir.J,2011,37(6):1411-1417.
10Nannini C,Medina-Velasquez YF,Achenbach SJ,et al.Incidence and mortality of obstructive lung disease in rheumatoid arthritis:a population-based study[J].Arthritis Care Res(Hoboken),2013,65(8):1243-1250.
